Indinavir: a pharmacologic and clinical review of a new HIV protease inhibitor.
Lacy
M K
MK
Department of Pharmacy Research, Hartford Hospital, USA.
Abriola
K P
KP
D019380:Anti-HIV Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D019469:Indinavir / Q000493:pharmacokinetics / Q000494:pharmacology*
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019469:Indinavir